Market Overview

Anti-CD22 Immunotherapeutics in October 2016: R&D and Business Tracker for Antibody-Drug Conjugates - Research and Markets

Share:
DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Anti-CD22 Immunotherapeutics in: October 2016 R&D and Business Tracker for Antibody-Drug Conjugates" report to their offering.

Anti-CD22 Immunotherapeutics in: October 2016 R&D and Business Tracker for Antibody-Drug Conjugates

This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. This issue forms part of the subscription service R&D and Business Tracker for Antibody-Drug Conjugates.

Featured presentations of October 2016 include the pipeline of CD22-targeted immunotherapeutics, the profile of US biotech Asana Biosciences and the profile of anti-nectin-6 antibody-drug conjugate AGS67E from Astellas Pharma.

The October 2016 issue of our R&D and Business Tracker service about antibody-drug conjugates contains:

R&D and Technology Tracker

- Pipeline changes

- Regulatory news

- Technology validations

- Manufacturing news

Business Tracker for:

- Company updates

- Collaboration

- Licensing

- Merger & acquisitions

- Financing

Clinical Trial Tracker

Scientific Publication Tracker

Featured ADC Profile: AGS67E

Featured Company Profile: Asana Biosciences

Featured Target Pipeline: Anti-CD22 Immunotherapeutics

CD-22 Targeted Immunotherapeutics include:

- Naked Antibodies & Combinations

- Radioimmunotherapeutics

- Immunotoxins

- Antibody-Drug Conjugates

- Autologous CAR T-Cells

Information about the anti-CD22 Immunotherapeutics pipeline is provided in a tabular format and fully referenced.

For more information about this report visit http://www.researchandmarkets.com/research/vnr2vp/anticd22

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Oncology Drugs, Oncology Drugs

View Comments and Join the Discussion!
 

Partner Center